📣 VC round data is live. Check it out!
- Public Comps
- Stille
Stille Valuation Multiples
Discover revenue and EBITDA valuation multiples for Stille and similar public comparables like Tristel, Standard Glass Lining, Prim, Bastide Le Confort Médical and more.
Stille Overview
About Stille
Stille AB manufactures and distributes medical devices. Its products include surgical equipment such as Surgical Scissors, Forceps, Curettes, Raspatories, Elevators, c-arm tables and instrument care education, among others.
Founded
1841
HQ

Employees
147
Website
Sectors
Financials (LTM)
EV
$249M
Valuation Multiples
Start free trialStille Financials
Stille reported last 12-month revenue of $69M and EBITDA of $14M.
In the same LTM period, Stille generated $35M in gross profit, $14M in EBITDA, and $8M in net income.
Revenue (LTM)
Stille P&L
In the most recent fiscal year, Stille reported revenue of $64M and EBITDA of $13M.
Stille is profitable as of last fiscal year, with gross margin of 48%, EBITDA margin of 20%, and net margin of 10%.
Financial data powered by Morningstar, Inc.
Stille Stock Performance
Stille has current market cap of $248M, and enterprise value of $249M.
Market Cap Evolution
Stille's stock price is $27.60.
Stille share price increased by 8.1% in the last 30 days, and by 19.1% in the last year.
Stille has an EPS (earnings per share) of $0.70.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $249M | $248M | 3.8% | 8.1% | 32.6% | 19.1% | $0.70 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialStille Valuation Multiples
Stille trades at 3.6x EV/Revenue multiple, and 17.2x EV/EBITDA.
EV / Revenue (LTM)
Stille Financial Valuation Multiples
As of May 26, 2026, Stille has market cap of $248M and EV of $249M.
Stille has a P/E ratio of 31.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Stille Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Stille Margins & Growth Rates
Stille grew revenue by 20% and EBITDA by 32% in the last fiscal year.
In the most recent fiscal year, Stille reported gross margin of 48%, EBITDA margin of 20%, and net margin of 10%.
Stille Margins
Stille Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Stille Operational KPIs
Stille's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Stille's Rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Stille's Rule of X is 85% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Stille Competitors
Stille competitors include Tristel, Standard Glass Lining, Prim, Bastide Le Confort Médical, Embecta, KORU Medical Systems, Paragon Care, Quipt Home Medical, Medika and Mercator Medical.
Most Stille public comparables operate across Medical Supplies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.8x | 3.5x | 13.9x | 12.7x | |||
| — | — | — | — | |||
| 0.9x | — | 6.3x | — | |||
| 1.0x | 1.0x | 4.6x | 4.6x | |||
| 1.3x | 1.3x | 3.3x | 3.9x | |||
| 4.5x | 4.1x | 280.9x | 180.9x | |||
| 0.2x | 0.2x | 7.1x | 6.2x | |||
| — | 1.1x | — | — | |||
This data is available for Pro users. Sign up to see all Stille competitors and their valuation data. Start Free Trial | ||||||
Stille M&A Activity
Stille has acquired 2 companies to date.
Last acquisition by Stille was on November 29th 2023. Stille acquired Fehling Instruments for $39M (EV/Revenue multiple of ).
Latest Acquisitions by Stille
| Description | Fehling Instruments is a Karlstadt-based manufacturer of neurosurgical instruments including aneurysm clips, dissectors, and suction tubes made from titanium and high-grade stainless steel. The company supplies over 5,000 products to hospitals in Germany, Europe, and the US, with ISO 13485 certification and repair services for reusable tools. | Kontron is a Munich-headquartered IT systems integrator delivering cloud infrastructure, data center solutions, cybersecurity, network services, and business applications for enterprises across Europe. |
| HQ Country | ||
| HQ City | Frankfurt | San Diego, CA |
| Deal Date | 29 Nov 2023 | 8 Jul 2021 |
| Valuation | $39M | $7M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Stille acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Stille
| When was Stille founded? | Stille was founded in 1841. |
| Where is Stille headquartered? | Stille is headquartered in Sweden. |
| How many employees does Stille have? | As of today, Stille has over 147 employees. |
| Is Stille publicly listed? | Yes, Stille is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Stille? | Stille trades under STIL ticker. |
| When did Stille go public? | Stille went public in 2005. |
| Who are competitors of Stille? | Stille main competitors include Tristel, Standard Glass Lining, Prim, Bastide Le Confort Médical, Embecta, KORU Medical Systems, Paragon Care, Quipt Home Medical, Medika, Mercator Medical. |
| What is the current market cap of Stille? | Stille's current market cap is $248M. |
| What is the current revenue of Stille? | Stille's last 12 months revenue is $69M. |
| What is the current revenue growth of Stille? | Stille revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of Stille? | Current revenue multiple of Stille is 3.6x. |
| Is Stille profitable? | Yes, Stille is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Stille? | Stille's last 12 months EBITDA is $14M. |
| What is Stille's EBITDA margin? | Stille's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Stille? | Current EBITDA multiple of Stille is 17.2x. |
| How many companies Stille has acquired to date? | As of May 2026, Stille has acquired 2 companies. |
| What was the largest acquisition by Stille? | $39M acquisition of Fehling Instruments on 29th November 2023 was the largest M&A Stille has done to date. |
| What companies Stille acquired? | Stille acquired Fehling Instruments and Kontron. |
| In how many companies Stille has invested to date? | Stille hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Stille
Lists including Stille
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

